Role of Low Dose Injectable Progesterone in Triggering Ovulation

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Low Dose, Progesterone, Triggering Ovulation

In brief

The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.

Key facts

Study ID

NCT06928844

Run by

The General Authority for Teaching Hospitals and Institutes

People needed

120

Starts

2025-04-15

Expected to finish

2025-08-01

Last updated by the study team

2025-04-16

Who can join

Age: 20 and older, up to 35. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age from 20 to 35 years.
• Infertile women.
• Basal follicle-stimulating hormone (FSH) level <10 mIU/ml.

You may not qualify if…

• Poor ovarian reserve.
• Immunological disease.
• Endometriosis.
• Uterine abnormality.
• Body mass index (BMI) >30 kg/m2.
• Endometrial thickness <8 or >12 mm on the day of triggering.

Where it is running

• Teaching Hospitals and Institutes — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.